Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALVO is expected to report earnings to fall 92.24% to 3 cents per share on November 12
Q3'25
Est.
$0.04
Q2'25
Beat
by $0.50
Q1'25
Beat
by $0.32
Q4'24
Missed
by $0.15
Q3'24
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of 50 cents, beating the estimate of 0 cents. With 594.40K shares outstanding, the current market capitalization sits at 2.50B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALVO showed earnings on August 13, 2025. You can read more about the earnings report here.